These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9675664)

  • 1. The case against routine post-operative therapy for prevention of recurrence in Crohn's disease.
    Breslin NP; Sutherland LR
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):226-30. PubMed ID: 9675664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In favour of prophylactic treatment for post-operative recurrence in Crohn's disease.
    Caprilli R; Taddei G; Viscido A
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):219-25. PubMed ID: 9675663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crohn disease: prevention and drug therapy].
    Gross V; Andus T; Schölmerich J
    Chirurg; 1995 Aug; 66(8):757-63. PubMed ID: 7587538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG; Sandborn WJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C; Scribano ML
    Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postoperative recurrence in Crohn's disease].
    Caprilli R; Taddei G; Viscido A
    Chir Ital; 1995; 47(5):25-32. PubMed ID: 9162601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties.
    Tromm A; Griga T; May B
    Hepatogastroenterology; 1999; 46(30):3124-35. PubMed ID: 10626173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy to reduce postoperative Crohn's disease recurrence.
    Achkar JP; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of surgically induced remission of Crohn's disease.
    Froehlich F; Juillerat P; Pittet V; Felley C; Mottet C; Vader JP; Michetti P; Gonvers JJ
    Digestion; 2007; 76(2):130-5. PubMed ID: 18239404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Azathioprine for prevention of postoperative recurrence in Crohn's disease].
    Abdelli MN; Ben Abdallah H; Houissa F; Bouali MR; Khediri MF
    Tunis Med; 2007 Jul; 85(7):569-72. PubMed ID: 18064988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic principles for chronic inflammatory bowel disease].
    Binder V; Munkholm P
    Ugeskr Laeger; 2001 Jan; 163(1):16-21. PubMed ID: 11586666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ; Feagan BG; Lichtenstein GR
    Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: can post-operative recurrence in Crohn's disease be prevented?
    Lémann M
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():22-8. PubMed ID: 16961740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ; Chu XQ; Shi XH; Zhou CL; Seng BW
    J Dig Dis; 2008 May; 9(2):84-8. PubMed ID: 18419641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.
    de Jong DJ; Bac DJ; Tan G; de Boer SY; Grabowsky IL; Jansen JB; Greinwald R; Naber TH
    Neth J Med; 2007 Oct; 65(9):339-45. PubMed ID: 17954953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.